RecruitingUrinary Incontinence, StressOverweight and/or Obesity
A Study to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or Overweight (VESPER-SUI)
Eligible age
18+ yrs
Accepts
Women
Locations
6 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to learn about the safety and effectiveness of berobenatide in adult women who have both stress urinary incontinence (SUI) and obesity or overweight. Participants will be in the study for about 63 weeks
Sponsor: Pfizer
You may qualify if…
- ✓ Adult women aged 18 years or older
- ✓ Body mass index (BMI) of 27 kg/m² or greater
- ✓ Have a diagnosis of stress urinary incontinence
- ✓ Willing and able to comply with study procedures
You may not qualify if…
- ✕ Have had urinary incontinence surgery
- ✕ Have taken medications (prescribed or over-the counter) intended to promote weight loss within 90 days prior to randomization
- ✕ Have recently received onabotulinumtoxin A (Botox) bladder injections or currently taking medications for urinary incontinence
- ✕ History of acute or chronic pancreatitis
- ✕ Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN-2)
- ✕ Have diabetes or laboratory assessments indicative of diabetes
- ✕ Have had a cardiovascular health condition within 90 days prior to randomization
- ✕ Are breastfeeding, pregnant, parturition in the past 12 months, planning to become pregnant in the following 12 months, or of childbearing potential and not using adequate contraception
Where it's recruiting
California
Citrus Heights · Sacramento
Florida
Boynton Beach · Miami
New Jersey
Warren Township
Pennsylvania
Horsham
Texas
Houston
Washington
Bellevue
Source: ClinicalTrials.gov · NCT07932925 · last updated 2026-11-19